Q1 FY27 snapshot
Announcement Date31-Jul-26
Revenue (Top Line)₹1,270 Cr
Net Profit (Bottom Line)₹157 Cr
Earnings Per Share (EPS)₹17.02
Expenses₹1,113 Cr
Net profit margin (calculated)12.4%
Strides Pharma Science Ltd. (STAR) Quarterly Results: Q1 FY27
Quick answer: Strides Pharma Science Ltd. (NSE: STAR) reported Q1 FY27 revenue of ₹1,270 Cr and net profit of ₹157 Cr, with earnings per share (EPS) of ₹17.02, announced on 31-Jul-26.
That works out to a net profit margin of about 12.4% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Strides Pharma Science Ltd.'s Q1 FY27 results
Revenue of ₹1,270 Cr is what Strides Pharma Science Ltd. earned before costs. Net profit of ₹157 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 12.4%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Strides Pharma Science Ltd. results FAQs
What were Strides Pharma Science Ltd.'s Q1 FY27 results?
Strides Pharma Science Ltd. (NSE: STAR) reported Q1 FY27 revenue of ₹1,270 Cr and net profit of ₹157 Cr, with earnings per share (EPS) of ₹17.02, announced on 31-Jul-26.
What is Strides Pharma Science Ltd.'s EPS for Q1 FY27?
Strides Pharma Science Ltd.'s earnings per share for Q1 FY27 was ₹17.02. EPS is net profit divided by the number of outstanding shares.
When did Strides Pharma Science Ltd. announce its Q1 FY27 results?
Strides Pharma Science Ltd. announced its Q1 FY27 results on 31-Jul-26.
What is Strides Pharma Science Ltd.'s net profit margin?
On the reported figures, Strides Pharma Science Ltd.'s Q1 FY27 net profit margin is about 12.4% (net profit ÷ revenue).